tirzepatide direct from lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Eli Lilly sues Mochi Health

Its estimated that 20% of American adults suffer from GERD, but its even more common among people taking GLP-1s

Its been linked to hormonal changes and even sexual dysfunction in some users (Mysore, 2012)

No one looks at the pharmacy side and says, This is the epitome of capitalism and market efficiency at its best. And whenever I see that, I see an opportunity

Provider-supervised tapering reduces these rebound effects

Understanding whether your provinces public healthcare plan covers semaglutide is crucial to calculating your true costs

I feel particularly fortunate to be representing our team at Honored to be recognized alongside these incredible leaders in the medical device field